Peginterferon beta-1a Alternatives Compared
| Peginterferon beta-1a | Ublituximab | Copaxone (glatiramer) |
|
|---|
| Peginterferon beta-1a | Ublituximab | Copaxone (glatiramer) |
|
|---|---|---|---|
|
Prescription only
Prescribed for Multiple Sclerosis. Peginterferon beta-1a may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Multiple Sclerosis. Ublituximab may also be used for purposes not listed in this medication guide. |
Prescription only
Copaxone is a combination of four amino acids that may be given to treat relapsing forms of multiple sclerosis in adults. It has been shown to significantly reduce the number of relapses but may be... View more |
|
| More about Peginterferon beta-1a | More about Ublituximab | More about Copaxone (glatiramer) | |
| Ratings & Reviews | |||
|
Peginterferon beta-1a has an average rating of 5.3 out of 10 from a total of 15 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 33% reported a negative effect. |
Ublituximab has an average rating of 8.3 out of 10 from a total of 13 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 8% reported a negative effect. |
Copaxone has an average rating of 7.6 out of 10 from a total of 133 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 16% reported a negative effect. |
|
| Drug Class | |||
| Side Effects | |||
| Generic Availability | |||
|
N/A |
N/A |
||
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms Available | |||
|
N/A |
N/A |
N/A |
|
| Brand Names | |||
| Plegridy | Briumvi | Other glatiramer brands include: Glatopa | |
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||
|
78 hours |
528 hours |
1 hour |
|
| CSA Schedule ** View glossary of terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
|
| Drug Interactions | |||
|
A total of 329 drugs are known to interact with Peginterferon beta-1a:
|
A total of 410 drugs are known to interact with Ublituximab:
|
A total of 1 drugs are known to interact with Copaxone:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | |||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||
| First Approval Date | |||
|
N/A |
December 28, 2022 |
December 20, 1996 |
|
| WADA Class View World Anti-Doping Agency classifications. | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient resources | |||
| Professional Resources | |||
| Related Treatment Guide | |||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.